A Arcusa
Overview
Explore the profile of A Arcusa including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
447
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Hernandez-Rabaza V, Hontecillas-Prieto L, Velazquez-Sanchez C, Ferragud A, Perez-Villaba A, Arcusa A, et al.
Neurobiol Learn Mem
. 2008 Jul;
90(3):553-9.
PMID: 18644245
The hippocampus is believed to play a role in processing information relative to the context in which emotionally salient experiences occur but evidence on the specific contribution of the hippocampal...
12.
Martin M, Lluch A, Segui M, Ruiz A, Ramos M, Adrover E, et al.
Ann Oncol
. 2006 Jun;
17(8):1205-12.
PMID: 16766587
Background: The aim of the study was to analyse the toxicity and health related quality of life (HRQoL) of breast cancer patients treated with FAC (5-fluorouracil, doxorubicin, cyclophosphamide) and TAC...
13.
Gonzalez-Martin A, Calvo E, Bover I, Rubio M, Arcusa A, Casado A, et al.
Ann Oncol
. 2005 Apr;
16(5):749-55.
PMID: 15817604
Background: The aim of this study was to determine whether the response rate for the paclitaxel-carboplatin combination is superior to carboplatin alone in the treatment of patients with platinum-sensitive recurrent...
14.
Pico C, Martin M, Jara C, Barnadas A, Pelegri A, Balil A, et al.
Ann Oncol
. 2003 Dec;
15(1):79-87.
PMID: 14679124
Background: A prospective randomized clinical trial was implemented to assess whether the concomitant or the sequential addition of tamoxifen to chemotherapy provides improved clinical benefit in the adjuvant treatment of...
15.
Treatment of oesophageal cancer with preoperative chemoradiotherapy may increase operative mortality
Balart J, Balmana J, Rius X, Salazar R, Gallen M, Navarro S, et al.
Eur J Surg Oncol
. 2003 Nov;
29(10):884-9.
PMID: 14624782
Aims: This phase II multicentric study evaluates a modified preoperative chemoradiotherapy schedule. Methods: Patients <75 years with potentially resectable neoplasm were eligible. Treatment included an initial course of CDDP 100...
16.
Bonfill X, Montes J, Roque M, Nogue M, Saigi E, Segui M, et al.
Med Clin (Barc)
. 2000 Sep;
114 Suppl 3:104-11.
PMID: 10994573
Background: The aim of this study was to assess the outcome in patients with lung cancer. Patients And Methods: Prospective study in 93 patients with lung cancer in 3 community...
17.
Cirera L, Balil A, Tusquets I, Cardona T, Arcusa A, Jolis L, et al.
J Clin Oncol
. 1999 Nov;
17(12):3810-5.
PMID: 10577853
Purpose: The efficacy of adjuvant chemotherapy in gastric cancer is controversial. We conducted a phase III, randomized, multicentric clinical trial with the goal of assessing the efficacy of the combination...
18.
Nogue M, Segui M, Saigi E, Arcusa A, Boleda M, Anton I
Cancer
. 1998 Jul;
83(2):254-8.
PMID: 9669807
Background: Protracted oral administration of tegafur (TG) and leucovorin (LV) attempts to simulate the continuous infusion of 5-fluorouracil, with a higher intracellular folate pool. In a prior dose-finding study with...
19.
Carles J, Domenech M, Gelabert-Mas A, Nogue M, Tabernero J, Arcusa A, et al.
Acta Oncol
. 1998 Jul;
37(2):187-91.
PMID: 9636014
The purpose of this study was to evaluate the antitumor activity of vinorelbine and oral estramustine phosphate in patients with metastatic, hormone-refractory prostate cancer. We evaluated the activity of this...
20.
Nogue M, Arcusa A, Morales S, Guasch I, Franquesa R, Boleda M, et al.
Oncology
. 1993 Jul;
50(4):235-7.
PMID: 8388553
Fifty-three patients with advanced non-small cell lung cancer (NSCLC) were treated with alternating two-drug schedules cisplatin/vindesine and ifosfamide/mitomycin. Objective response (complete and partial response) was obtained in 31% (confidence limits...